Introduction
In-stent stenosis is a well-described delayed complication of angioplasty and stenting for atheromatous disease. 1, 2 Detection of high-risk in-stent restenosis would identify a subgroup of patients who may benefit from close observation/ early treatment. Digital subtraction angiography (DSA) is the gold standard imaging modality for follow-up of stent patency, but is invasive in nature and associated complication rate (range: 1.8-2.1%) would limit its use for repeated and long-term evaluation. Various noninvasive imaging modalities are described for in-stent stenosis evaluation. However, exact accuracy of each modality is not widely studied.
Based on previous evidence of SSYLVIA trial, 1 in which stenosis > 50% was grouped as high-risk group, the delayed in-stent stenosis in our study also defined > 50% delayed instent stenosis as "significant stenosis" requiring at least clinical attention/close follow-up/intervention. Hence, we aimed to study accuracy of contrast-enhanced magnetic resonance angiography (CE-MRA) and time-of-flight (TOF)-MRA in detection of significant delayed in-stent stenosis as compared with DSA.
Material and Methods

Patient Selection
The study was a retrospective-prospective evaluation of patients who underwent endovascular stent placement in intracranial circulation (defined as cavernous internal carotid artery and beyond, V4 vertebral artery and beyond), who had follow-up MRA December 2015. Patients treated with covered stent and stented for atherosclerotic stenosis were excluded from the study. In addition, interval of more than 1 month between MRA and DSA were excluded. Medical records were reviewed for patient demographic details such as age, sex, clinical presentation, DSA and MRA study, treatment given including medical and endovascular therapy, and follow-up. A few patients' MRA was retrospectively evaluated, while a few patients were prospectively followed with DSA/MRA.
Image Acquisition
MR imaging of the brain was performed using a 12-channel matrix coil on a 1.5 T clinical scanner (Avanto, SQ Engine; Siemens, Erlangen, Germany). Digital subtraction angiogram was obtained using a biplane neuro angiographic suit (Innova 3131, GE Medical systems, LLC, Milwaukee, Wisconsin, United States) with standard protocols, by transfemoral route and selective acquisition of vessels of interest in standard angiographic projections by iodinated contrast injection (Omnipaque 320; GE Healthcare, Princeton, New Jersey, United States).
Image Analysis
Four sets of MR images (TOF-MRA volume-rendered images, TOF-MRA source images, CE-MRA volume-rendered images, CE-MRA source images) were evaluated independently and in a randomized fashion by two experienced neuroradiologists (experience of reader 1: 10 years and reader 2: 5.5 years) and any deviation was resolved by consensus. Percentage stenosis was measured by using following formula, percent stenosis ¼ (1 À smallest in-stent diameter/diameter at the proximal/ distal normal vessel segment) Â 100. This calculation is a onedimensional view. If there are poor quality images in any one of the sets, the entire patient image sets were excluded from the study. We defined "significant in-stent stenosis" as ! 50% stenosis requiring clinical attention and further evaluation/ intervention. "Delayed" in-stent stenosis was defined as instent stenosis 3 months after stent deployment. The stenosis in five sets of images (1 DSA þ 4 MRA) was grouped into < 50% and ! 50% stenosis for statistical analysis. indicating the lesser role of platelet activation by stent as a direct cause for delayed in-stent stenosis. CE-MRA reformatted image, though less sensitive as compared with CE-MRA source image, both these image sets showed no statistically significant difference. In addition, the reformatted images were also statistically insignificant as compared with DSA in detection of > 50% stenosis.
Statistical Analysis
Discussion
Delayed in-stent stenosis is increasingly identified in different stents, though exact treatment remains controversial. The reported incidence of Neuroform in-stent stenosis is 5.8% in patients with symptomatic intracranial stenosis. 4 Intracranially stented patients need frequent and longterm follow-up for stent patency evaluation. Hence, different noninvasive modalities are being evaluated for delayed instent stenosis. Modification of regular computed tomography angiogram and contrast enhanced trans cranial Doppler (CE-TCD) is found to be useful for intracranial stenosis evaluation, 5,6 a case report of utility of CE-TCD in intracranial stent evaluation also been described. 7 Though the utility of TOF-MRA and CE-MRA in in-stent stenosis has been described, accuracy of each modality was not been evaluated in detail. In a recent study of various MRA techniques for the evaluation of in-stent flow, CE-MRA showed better flow signals. 8 In our study, CE-MRA identified significant stenosis (! 50% stenosis þ occlusion) correctly in all cases. However, as compared with DSA, CE-MRA showed 7 (35%) cases of less than 50% stenosis which is significantly less than previously reported 64%.
One of asymptomatic patient revealed 50% stenosis of Neuroform stent during follow-up angiography; he was treated with tirofiban infusion. Following tirofiban infusion, the stenosis reduced significantly. The other patient with Leo stent occlusion was managed conservatively due to his asymptomatic clinical status and presence of other comorbidities. There was no statistically significant difference in the involvement between Neuroform and Leo stents.
In a series of 14 patients with symptomatic intracranial stenosis, quantitative MRA (QMRA) showed low specificity and positive predictive value in detecting in-stent stenosis compared with our series. 8 In this study, CE-MRA reformatted images showed better specificity and positive predictive value, though sensitivity and negative predictive value is low (►Table 2). As against QMRA, the CE-MRA technique is easy to perform as well for interpretation, less subjected to artifacts from variable velocities. 9 Our study show high sensitivity and specificity of CE-MRA source image for detection of significant delayed in-stent stenosis.
Limitations of the study were (1) small number of cases in the cohort, the findings needs to support by larger study, (2) the study was retrospective-prospective study. We suggest need for prospective blinded study. (3) CE-MRA showed 39% false positivity for less than 50% stenosis. (4) The number of Solitaire AB (Covidien) and Enterprise stents (Codman) were very less, hence direct comparison between these two stents against other stents were not possible. (5) Larger field of view (including neck þ brain) used for CE-MRA image acquisition likely result in spread of acquired data over larger pixel. This limitation could be overcome by using small FOV for intracranial circulation only. This modified technique may further decrease false positive cases of delayed in-stent stenosis, though this aspect was not studied in the current study.
Conclusion
Development of delayed in-stent stenosis in nonatherosclerotic intracranial stenting is 11%. Even though CE-MRA source image analysis give false positive result in stenosis < 50%, it is a good imaging tool for detection and follow-up of significant (> 50%) intracranial in-stent stenosis.
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